Tetanus is a rare condition in the Western world although relatively common in developing countries. The literature includes very few controlled trials and relatively few case reports describing the effectiveness of the wide range of treatment modalities. General supportive management in the intensive care unit, neuromuscular blocking drugs, remains the mainstay in severe cases. Novel therapeutic approaches include magnesium infusion, intrathecal baclofen and immunotherapy. None of these is universally applicable or successful and many cases require a multi-modal approach. We describe a case of severe tetanus contracted from intramuscular drug abuse, and discuss its management.
CASE HISTORY
A 29-year-old female intravenous and intramuscular drug abuser presented to the accident and emergency department complaining of abdominal pain. She reported using cocaine and injecting heroin subcutaneously in the previous 24 hours. Her partner mentioned she had experienced "spasms" over the regularly injected heroin subcutaneously. She was admitted to the acute medical ward for further investigation.
Approximately 12 hours after admission she became increasingly agitated, confused and uncooperative. Nuchal rigidity was noted. She appeared to be having seizures, for which intravenous midazolam was administered. In view of the possible diagnosis of meningism a CT scan of her head was requested. On arrival in the radiology department, increasing trismus and ventilatory depression were noted. As these were severe and progressive, anaesthesia was induced with propofol and tracheal intubation was facilitated by suxamethonium 100 mg. An endotracheal tube was readily passed. The lungs were easily ventilated with oxygen-enriched air. Severe neck stiffness, noted at the time of intubation, the brain was normal.
Following transfer to the intensive care unit, she for muscle stiffness, using 30% oxygen in air. Prinexamination demonstrated her pupils were 3 mm, equal and reactive to light. She displayed marked neck stiffness and increased upper limb tone normal. Of note, an abscess was found on the right forearm. 
Intrathecal Baclofen
Intensive Care Unit, St James's University Hospital, Leeds, United Kingdom This report discusses the issues involved in the diagnosis and management of tetanus. A 29-year-old female with a history of illicit drug use presented with progressive tetany secondary to an abscess on her forearm from subcutaneous injections. She was managed in the intensive care unit for 29 days and was discharged to the ward. The main issue in her management was control of tetanic episodes interfering with ventilation and resistant to intrathecal baclofen. Other therapeutic strategies aimed at reducing spasms included magnesium, atracurium, pancuronium, midazolam, propofol and dantrolene. We conducted searches on Medline, PUBMED and the Cochrane Database of Systematic Reviews using the following terms: tetanus, treatment, therapy, drug abuse, magnesium, baclofen and human anti-tetanus immunoglobulin (hAIG). The current strategies involved in treating tetanus are discussed.
Gram-positive bacilli and cocci from the forearm abscess. Blood cultures were negative. A lumbar puncture was performed. This was essentially normal and no organisms were seen. However her peripheral 9 9 rhabdomyolysis or widespread skeletal muscle damage.
At the time of admission to the intensive care unit we therefore considered a differential diagnosis of meningitis, neuroleptic malignant syndrome, serotonin syndrome or tetanus. Over the course of the evening she developed progressive truncal rigidity and intermittent episodes of muscle spasm.
The pus sample from her forearm abscess subse-Clostridium tetani. She was treated daily and human anti-tetanus immunoglobulin. She was immunized against tetanus.
a variety of agents and combinations were used to control them. These included non-depolarizing neuromuscular blockers atracurium and pancuronium, dantrolene, intrathecal baclofen, magnesium sulphate as an intravenous infusion, propofol and midazolam. We used intrathecal baclofen both as a bolus and as an infusion. The intrathecal catheter was placed the intrathecal catheter. A continuous infusion of days. This was ineffective in controlling the muscle the initial bolus dose, requiring vasopressor support. The intrathecal catheter was removed at the end Moreover, the nursing staff were not familiar with the Magnesium sulphate was administered as an intratitrated to keep the serum magnesium between effects noted from magnesium at this plasma concentration.
of autonomic instability characterized by periods of hypertension and hypotension. These were relatively easy to control with either noradrenaline or intracardia were encountered.
A tracheostomy was performed on day three to nosocomial pneumonia 1 . She was managed in the intensive care unit for 30 days during which time her spasms became less frequent and less severe. On day 30 she was transferred to the infectious diseases ward for further rehabilitation. At hospital discharge the patient remained dependent on a wheelchair because of occasional thigh and leg spasms, but was continuing to improve.
Clostridium tetani is a Gram positive bacillus 2 . Tetanus toxin is released by Clostridium tetani and is preferentially taken up by motor nerves and is then transported in a retrograde direction into the central nervous system 3 . It cleaves vesicle-associated membrane protein II at a single peptide bond. Vesicle-associated membrane protein II is essential for synaptic release of neurotransmitters 4 . The toxin preferentially affects the gamma-aminobutyric acid (GABA) inhibitory interneurons afferent to motor nerves in the spinal cord and brainstem . Severe forms can affect the autonomic nervous system resulting in autonomic instability .
per year . There are relatively few good controlled studies into the effective management of tetanus . This stems from two reasons. First, there is rarity in developed countries and second, there is a lack of resources to conduct studies in developing countries where the condition has a greater incidence 9 .
The key elements in the management of tetanus include neutralization of tetanus toxin, wound debridement, antibiotic therapy, respiratory support and management of spasms and autonomic dysfunction 10 .
Although there are few trials investigating the management of tetanus 9 , intensive care management 11 . In our case, muscle spasm causing secondary muscle damage was the most clinically important and recurring problem. Most studies so far have focused on treatment strategies which reduce the need for nondepolarizing neuromuscular blockers. The best trials to date have studied magnesium 12-13 and intrathecal immunoglobulin combined with intramuscular immunoglobulin 14 .
This prompted us to review the best evidence and current strategies for spasms in tetanus. We conducted searches on Medline, PubMed and the Cochrane magnesium, baclofen. Only a minority of these were relevant to the present case, according to severity of clinical presentation or relevance to critical care practice.
Magnesium
Magnesium is the most extensively investigated of these treatment modalities. Even so, there are only three uncontrolled studies with regards to its series of magnesium use in ten tetanus patients in 13 . Magnesium reduced autonomic instability. However, the authors noted that infusion rates of looked at forty patients resulted in effective control of muscle spasms in throughout treatment. Most patients were able to mobilize by the second to third week with this regimen. However, the grading of severity for each patient was not reported and therefore it is not clear how many patients had severe tetany (grades III-IV).
In view of the risk of profound muscle relaxation, magnesium therapy should be restricted to use in an intensive care unit .
Immunotherapy
In a randomized controlled trial of 120 patients comparing intrathecal plus intramuscular human anti-tetanus immunoglobulin (hAIG) against intraintrathecal administration 14 . Patients treated with intrathecal plus intramuscular immunoglobulin had less severe disease grading at ten days compared to from a shorter hospital stay, lower frequency of spasms and shorter requirement for invasive ventilation. There was no difference in mortality between groups. However, this may be because the study was underpowered for this end-point. Importantly, the side-effects were minimal with only received intrathecal treatment.
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Benzodiazepines have been favoured because of their positive GABA effects, increasing transmission at inhibitory interneurons . Initially, diazepam was used however midazolam is now favoured because of its ease of administration compared to diazepam and its lack of active metabolites 19 . However, there have not been any properly controlled studies to date on the . The Cochrane which met their inclusion criteria on the use of diazepam versus phenobarbitone and chlorpromazine in the treatment of tetanus in neonates. It concluded that diazepam alone may be more effective. However, it did stress that the studies were small, limited, "conclusions to support change in current clinical practice" 21 .
Intrathecal baclofen
Baclofen is a GABA B agonist that reduces polydependent muscle hypotonia. However, it does not cross the blood brain barrier, hence the need for intrathecal administration [22] [23] . In an uncontrolled study using intrathecal baclofen 24 in 10 patients, intermittent
The authors claimed an improvement approximately one and a half hours after administration and that its use was associated with a lower requirement for neuromuscular blockers. Side-effects included sedation and ventilatory depression. Muller and co-workers reported the use of intrathecal baclofen in three patients. Baclofen was administered as a continuous intrathecal infusion in an attempt to minimize respiratory depression and sedation. Again, the authors claimed a reduced need for neuromuscular blockers. In a study on four , an improvement in spasm control and a reduction in benzodiazepine requirements was noted in all four patients. In that series, the catheter position was at the lower thoracic level (T10-T11). It was hypothesized that spasms in the upper extremities may be better controlled by higher catheter placement. There is evidence for limited regional spread within baclofen, suggesting that catheter placement may be of some relevance but that any chosen level will . Engrand et al studied intrathecal baclofen in these data with 11 historical controls that did not receive intrathecal baclofen. There was a reduction the intrathecal baclofen group. Interestingly, two patients in the study group had contracted tetanus via intramuscular injection. Intrathecal baclofen was ineffective on the spasms in one of the Engrand and co-workers patients receiving a mean dose of and survived to discharge from intensive care on Three other case reports were found in the literature in which intrathecal baclofen was used successfully. Boots and co-workers described two cases where a tunnelled intrathecal catheter was used successfully and enabled a reduction in sedation and paralysis requirements . Trampitsch and colleagues found similar results when they used intrathecal baclofen on one patient 29 . Engrand and co-workers reported another case in 2001 where a pregnant patient was successfully treated with intrathecal baclofen which led to a reduced requirements for diazepam 30 .
Others have also reported that tetanus contracted through subcutaneous, intramuscular or intravenous injection appears to produce particularly severe spasms peaking at about three weeks and resistant to treatment 31-33 . The reasons for this are unknown but could relate to concentration or distribution of toxin within the central nervous system. It is possible that intrathecal baclofen requirements in tetanus contracted via injection may require higher doses than we administered, or indeed may be resistant to intrathecal baclofen for reasons yet to be determined 32 . Engrand and co-workers suggested that intrathecal baclofen may not be appropriate for severe forms of tetanus requiring intubation and neuromuscular blockade. 34 . It is possible that due to a relatively sub-therapeutic infusion rate, in drug-users. In our institution there was the added factor of unfamiliarity with the treatment and reluctance by nursing staff to use this modality.
An effective method for the treatment of muscle spasm in tetanus remains elusive. Some studies have shown promise but conclusive evidence is still lackadministration of high-dose magnesium. High plasma concentrations did not have a clinically detrimental anti-tetanus immunoglobulin, midazolam, magnesium, intrathecal baclofen and propofol, we were still reliant on neuromuscular blocking drugs for much of the from intrathecal baclofen, consistent with the view that tetanus contracted via subcutaneous injections randomized controlled trials are likely to remain impracticable. A detailed international registry strategies. 
